Ampio Pharmaceuticals (AMPE) Competitors

Ampio Pharmaceuticals (NYSE:AMPE) and Genocea Biosciences (NASDAQ:GNCA) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability, community ranking and analyst recommendations.

Which has more volatility and risk, AMPE or GNCA?

Ampio Pharmaceuticals has a beta of 3.67, indicating that its share price is 267% more volatile than the S&P 500. Comparatively, Genocea Biosciences has a beta of 1.61, indicating that its share price is 61% more volatile than the S&P 500.

Do insiders & institutionals believe in AMPE or GNCA?

5.7% of Ampio Pharmaceuticals shares are held by institutional investors. Comparatively, 0.6% of Genocea Biosciences shares are held by institutional investors. 3.3% of Ampio Pharmaceuticals shares are held by insiders. Comparatively, 1.6% of Genocea Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Which has better valuation and earnings, AMPE or GNCA?

Ampio Pharmaceuticals has higher earnings, but lower revenue than Genocea Biosciences. Ampio Pharmaceuticals is trading at a lower price-to-earnings ratio than Genocea Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ampio Pharmaceuticals	N/A	N/A	-$8.63M	-$11.01	0.00
Genocea Biosciences	$1.91M	0.00	-$33.20M	-$0.61	N/A

Does the media favor AMPE or GNCA?

In the previous week, Ampio Pharmaceuticals and Ampio Pharmaceuticals both had 1 articles in the media. Ampio Pharmaceuticals' average media sentiment score of 0.00 equaled Genocea Biosciences'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ampio Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Genocea Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Does the MarketBeat Community believe in AMPE or GNCA?

Genocea Biosciences received 388 more outperform votes than Ampio Pharmaceuticals when rated by MarketBeat users. Likewise, 58.08% of users gave Genocea Biosciences an outperform vote while only 0.00% of users gave Ampio Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
Ampio Pharmaceuticals	Outperform Votes No Votes	Underperform Votes 47 100.00%
Genocea Biosciences	Outperform Votes 388 58.08%	Underperform Votes 280 41.92%

Is AMPE or GNCA more profitable?

Ampio Pharmaceuticals' return on equity of -149.00% beat Genocea Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ampio Pharmaceuticals	N/A	-149.00%	-103.79%
Genocea Biosciences	N/A	-182.88%	-62.76%

Do analysts prefer AMPE or GNCA?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ampio Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Genocea Biosciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Summary

Genocea Biosciences beats Ampio Pharmaceuticals on 6 of the 11 factors compared between the two stocks.